Randomized clinical trial: the effects of pregabalin for centrally mediated abdominal pain syndrome

BACKGROUND: Pregabalin is worldwidely licensed for the treatment of a variety of pain syndromes and supposed to be a potential candidate for the centrally mediated abdominal pain syndrome (CAPS). OBJECTIVES: To investigate the efficacy of pregabalin on nociceptive and emotional symptoms in CAPS pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ri, Wang, Yanyan, Han, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989377/
https://www.ncbi.nlm.nih.gov/pubmed/36895281
http://dx.doi.org/10.1177/17562848231152334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989377/
https://www.ncbi.nlm.nih.gov/pubmed/36895281
http://dx.doi.org/10.1177/17562848231152334

Ejemplares similares